J. Cayuela

发表

Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: a multicenter study of 51 patients.

F. Sigaux, A. Baruchel, C. Preudhomme, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society

J. Bourhis, H. Dombret, A. Baruchel, 2003, Bone Marrow Transplantation.

Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program

H. Cavé, J. Dongen, J. Aerts, 2003, Leukemia.

A certi ﬁ ed plasmid reference material for the standardisation of BCR – ABL1 mRNA quanti ﬁ cation by real-time quantitative PCR

D. Colomer, T. Lion, M. Jansson, 2015 .

Prospective multicentric molecular study for poor prognosis fusion transcripts at diagnosis in adult B-lineage ALL patients: the LALA 94 experience

H. Dombret, E. Macintyre, T. Fest, 2006, Leukemia.

Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinib

S. Hayette, I. Tigaud, J. Magaud, 2005, Leukemia.

TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia.

J. Cayuela, C. Bastard, B. Debuire, 1996, Leukemia.

Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association

H. Dombret, C. Preudhomme, P. Fenaux, 2011, Leukemia.

Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group

H. Dombret, A. Vekhoff, S. Chevret, 2005, Leukemia.

Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy

X Thomas, F. Sigaux, J. Cayuela, 2002, Leukemia.

Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias

F. Sigaux, J. Soulier, E. Clappier, 2006, Leukemia.

PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study

J. D. Vos, P. Brousset, J. Soulier, 2009, Leukemia.

Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study

H. Dombret, A. Delannoy, J. Gabert, 2006, Leukemia.

The majority of myeloid‐antigen‐positive (My+) childhood B‐cell precursor acute lymphoblastic leukaemias express TEL‐AML1 fusion transcripts

F. Sigaux, A. Baruchel, E. Macintyre, 1997, British journal of haematology.

Personalized daily doses of imatinib by therapeutic drug monitoring increase the rates of molecular responses in patients with Chronic Myeloid Leukemia - Final results of the randomized Optim imatinib study: Co-028

J. Cayuela, P. Cony-Makhoul, P. Rousselot, 2015 .

Influence of CD34 cell selection on the incidence of mixed chimaerism and minimal residual disease after allogeneic unrelated donor transplantation

H. Esperou, G. Socié, E. Gluckman, 1998, Leukemia.

An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions

F. Sigaux, J. Soulier, E. Clappier, 2014, Leukemia.

A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR

H Emons, V Kairisto, S Trapmann, 2014, Leukemia.

Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias.

F. Sigaux, J. Cayuela, J. Hébert, 1994, Blood.

Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(ϕ)-LMC GROUP)

J. Cayuela, C. Preudhomme, M. Tulliez, 2006, Leukemia.

Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurements

J. Cayuela, T. Lion, J. Saldanha, 2007, Leukemia.

First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia

J. Cayuela, P. Cony-Makhoul, M. Tulliez, 2012, Leukemia.